Prof. Dr. med. Fabian Müller

Department of Medicine 5 – Haematology and Oncology Professur für CAR-T-Zell-Therapie

CAR-T CELL TREATMENT OF REFRACTORY SYSTEMIC LUPUS ERYTHEMATOSUS- SAFETY AND PRELIMINARY EFFICACY DATA FROM THE FIRST FOUR PATIENTS (2022) Schett G, Böltz S, Müller F, Kleyer A, Völkl S, Aigner M, Gary R, et al. Conference contribution The EMT transcription factor ZEB1 governs a fitness-promoting but vulnerable DNA replication stress response. (2022) Schuhwerk H, Kleemann J, Gupta P, van Roey R, Armstark I, Kreileder M, Feldker N, et al. Journal article Successful Generation of CD19 Chimeric Antigen Receptor T Cells from Patients with Advanced Systemic Lupus Erythematosus (2022) Kretschmann S, Völkl S, Reimann H, Krönke G, Schett G, Achenbach S, Lutzny-Geier G, et al. Journal article Anti-CD19 CAR T cell therapy for refractory systemic lupus erythematosus (2022) Mackensen A, Müller F, Mougiakakos D, Böltz S, Wilhelm A, Aigner M, Völkl S, et al. Journal article Reduced cytotoxicity by mutation of lysine 590 of Pseudomonas exotoxin can be restored in an optimized, lysine-free immunotoxin. (2022) Ammon AM, Mellenthin L, Emmerich C, Naschberger E, Stürzl M, Mackensen A, Müller F Journal article Human CD22-transgenic, primary murine lymphoma challenges immunotherapies in organ-specific tumor microenvironments (2021) Gsottberger F, Brandl C, Wendland K, Petkovic S, Emmerich C, Erber R, Geppert CI, et al. Journal article Purification and functional characterization of CD34(+) cells from cryopreserved apheresis products of patients with bone marrow infiltrating malignancies (2021) Wendland K, Petkovic S, Aigner M, Strobel J, Mackensen A, Müller F Conference contribution Synergy of simultaneous activation of cell death pathways of unfolded protein response and of protein synthesis inhibition converges at IRE1a-immunotoxins generate a therapeutic window (2021) Gsottberger F, Meier C, Ammon AM, Petkovic S, Mellenthin L, Krumbholz M, Metzler M, et al. Conference contribution The EMT transcription factor ZEB1 blocks osteoblastic differentiation in bone development and osteosarcoma (2021) Ruh M, Stemmler M, Frisch I, Fuchs K, van Roey R, Kleemann J, Roas M, et al. Journal article Neue antikörperbasierte Therapien in der Hämatologie (2021) Müller F Journal article, Review article